New blood test set to detect ‘forgotten’ women’s cancer
27 February, 2013Garvan researchers, in collaboration with The Gynaecologic Cancer Centre at Royal Hospital for Women, are developing the first-ever early detection test for ovarian cancer based on epigenetic changes that are associated with ovarian cancer risk.
UC researching new forms of tumour detection
11 February, 2013Researchers at the University of Canterbury are working on new forms of tumour detection in the hope of reducing the annual cancer toll.
Researchers identify enzyme involved in deadly brain tumours
25 January, 2013In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and the malignant tumour glioblastoma multiforme.
Scientists pinpoint molecular signals that make some women prone to miscarriage
21 January, 2013Scientists have identified molecular signals that control whether embryos are accepted by the womb and appear to function abnormally in women who have suffered repeated miscarriages.
Potential new treatment for gastrointestinal cancers discovered
17 January, 2013Researchers have identified a complex of proteins that promotes the growth of some types of colon and gastric cancers, and shown that medications that block the function of this complex have the potential to be developed into a new treatment for these diseases.
Saliva glands may diagnose Parkinson’s disease
15 January, 2013 by Lauren DavisNew research from Mayo Clinic in Arizona and Banner Sun Health Research Institute suggests that testing a portion of a person’s saliva gland may be a way to diagnose the degenerative disorder Parkinson’s disease. The study will be presented at the American Academy of Neurology’s annual meeting in San Diego in March.
Alzheimer’s to be diagnosed online
10 January, 2013The early onset of Alzheimer’s disease could be detected using a simple online test, according to scientists from the Queensland Brain Institute (QBI) at The University of Queensland (UQ).
Researchers find new molecule to target in pancreatic cancer treatment
08 January, 2013Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95% of pancreatic cancer cases.
Growing tumours grows hope for children with cancer
21 December, 2012 by Lauren DavisDiffuse Pontine Glioma (DIPG) may not be particularly well known, but according to oncologist Dr David Ziegler, it is “one of the most common and the most aggressive brain tumours we see in kids”. Now, Dr Ziegler and colleagues from the Children’s Cancer Institute of Australia (CCIA) have set out to grow their own tumours in the institute’s ACRF Drug Discovery Centre.
National initiative to personalise breast cancer treatment
20 December, 2012Researchers are working on a solution for a large number of breast cancer patients who do not respond to chemotherapy, thanks to $5 million in funding.
Collaboration to develop compound to boost vaccine efficacy
07 December, 2012The University of Melbourne has announced an agreement with vaccine company Bio Farma to develop an adjuvant - a vaccine delivery system which could boost the effectiveness of vaccines for a range of infectious diseases.
EPO doping in elite cycling: no evidence of benefit but high risk of harm
07 December, 2012The drug erythropoietin, often called EPO, is banned from sports because it is believed to enhance an athlete’s performance and give people who use it an unfair advantage over unenhanced competitors. A new systemic review of existing research reveals that there is no scientific evidence that it does enhance performance, but that its use in sport could place a user’s health and life at risk.
Breath test could possibly diagnose colorectal cancer
06 December, 2012A new study published in the British Journal of Surgery (BJS) has demonstrated for the first time that a simple breath analysis could be used for colorectal cancer screening.
Scientists identify depression and anxiety biomarker in youths
01 December, 2012Scientists from the University of Cambridge have discovered a cognitive biomarker - a biological indicator of a disease - for young adolescents who are at high risk of developing depression and anxiety. Their findings have been published in the journal PLoS ONE.
Pairing blood test and gene sequencing to detect cancer
30 November, 2012Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
